Hege F. Berg

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 06, 2025

Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions.

Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions.

Journal: Translational oncology

Published: May 15, 2025

Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining.

Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining.

Journal: Gynecologic oncology

Published: February 25, 2025

Evaluation of early chemotherapy response by combining static- and dynamic [18F]FDG-PET with diffusion-weighted MRI in subcutaneous patient-derived endometrial cancer mouse models.

Evaluation of early chemotherapy response by combining static- and dynamic [18F]FDG-PET with diffusion-weighted MRI in subcutaneous patient-derived endometrial cancer mouse models.

Journal: EJNMMI research

Published: January 13, 2025

Frequency of ERBB2-Low Expression in Endometrial Cancer.

Frequency of ERBB2-Low Expression in Endometrial Cancer.

Journal: JAMA oncology

Published: September 05, 2024

Multiplex single-cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer.

Multiplex single-cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer.

Journal: Molecular oncology

Published: August 26, 2024

Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer.

Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer.

Journal: BJC reports

Published: July 02, 2024

Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.

Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 01, 2024

Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.

Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.

Journal: Scientific reports

Published: February 23, 2024

Corrigendum to "Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease" [EBioMedicine 92 (2023) 104595].

Corrigendum to "Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease" [EBioMedicine 92 (2023) 104595].

Journal: EBioMedicine

Published: November 17, 2023

MRI radiomics captures early treatment response in patient-derived organoid endometrial cancer mouse models.

MRI radiomics captures early treatment response in patient-derived organoid endometrial cancer mouse models.

Journal: Frontiers in oncology

Published: November 07, 2023

Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease.

Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease.

Journal: EBioMedicine

Published: January 31, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026